• Middle East
  • North Africa
  • Global
  • Business
  • Finance
  • Technology
  • Press
  • About Us
    • Press Release Distribution Services
    • Submit Press Release
    • Contact Us
Submit Press Release
Search
Close
Search
Close
Home Press

Cardiac Marker Testing Market worth $5.5 billion by 2025

admin by admin
January 14, 2022
in Press
Cardiac Marker Testing Market worth $5.5 billion by 2025
Share on FacebookShare on Twitter


 


(EMAILWIRE.COM, January 13, 2022 ) According to the new market research report “Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) – Global Forecasts to 2025″, published by MarketsandMarkets™, the market is estimated to be USD 3.6 billion in 2020 and projected to reach USD 5.5 billion by 2025, at a CAGR of 8.9%.

Browse in-depth TOC on “Cardiac Marker Testing Market”

102 – Tables

37 – Figures

167 – Pages

Download PDF Brochure: –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64885447

The growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are expected to restrain market growth to a certain extent.

The cardiac marker testing market includes major Tier I and II suppliers like Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), and Danaher Corporation (US). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well.

The cardiac marker testing market is also faced a period of short-term negative growth, which can be attributed to factors such as a greater than 50% drop in the number of patients with cardiovascular conditions and those diagnosed with myocardial infarction. All areas of cardiology service provision sustained significant reductions, which included outpatient clinics, investigations, procedures, and cardiology community services such as cardiac rehabilitation.

Wide use of reagents and kits in all basic diagnostic activities in laboratories, academic institutes, and POC settings is expected to result in the segment occupying the majority of the cardiac marker testing market share

Growing number of cardiac marker testing procedures, accessibility to a wide range of cardiac biomarker reagents and kits, and the growing demand for reliable, specific, and faster detection of cardiovascular diseases at an early stage are the key growth factors for this segment.

Troponin I and T estimated to be the fastest-growing market

Troponin I and T is estimated to be the fastest-growing segment in the cardiac marker testing market. The large share of this segment can be attributed high sensitivity and specificity, long elevation times, and rapid prediction of outcome or mortality.

North America is estimated to be the largest market due increasing incidence of cardiovascular diseases, growing public and private investments, NIH support for the development of novel cardiac biomarkers, and the rising geriatric population.

Request Sample Pages: –https://www.marketsandmarkets.com/requestsampleNew.asp?id=64885447

Asia Pacific likely to emerge as the largest cardiac marker testing market, globally

Asia Pacific is estimated to be the fastest-growing market for cardiac marker testing during the forecast period. The Asia Pacific market is driven due increased healthcare spending by a larger population base, healthcare infrastructure modernization, and the rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas) in Asia Pacific countries.

Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), and Danaher Corporation (US) are the key players in the global cardiac marker testing market.

Browse Related Reports:

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html



Source link

Previous Post

Liquid Biopsy in Breast Cancer Market Worth $411.1 Million

Next Post

ECMO Machine Market Worth 305.3 Million USD

RelatedPosts

Air Motor Market expected to hit USD 1.08 Bn by 2029 during the forecast period
Press

Air Motor Market expected to hit USD 1.08 Bn by 2029 during the forecast period

 (EMAILWIRE.COM, March 20, 2023 ) Pune 7 Mar 2023: As per the Maximize Market research, a global business...

by admin
March 20, 2023
Electrolyzers Market worth $23.6 Billion by 2028
Press

Electrolyzers Market worth $23.6 Billion by 2028

 (EMAILWIRE.COM, March 20, 2023 ) The global Electrolyzers Market is projected to reach USD 23.6 billion in 2028...

by admin
March 20, 2023
Infusion Pump Market: Growing adoption of specialty infusion systems
Press

Infusion Pump Market: Growing adoption of specialty infusion systems

 (EMAILWIRE.COM, March 20, 2023 ) The adoption of several specialty infusion pumps is on the rise globally. Patient-controlled...

by admin
March 20, 2023
Methyl Soyate Market expected to hit USD1.57 Bn by 2029 throughout the forecast period
Press

Methyl Soyate Market expected to hit USD1.57 Bn by 2029 throughout the forecast period

 (EMAILWIRE.COM, March 20, 2023 ) Pune 6 Mar 2023: As per the Maximize Market research, a global business...

by admin
March 20, 2023
Load More

Advertize

Latest Post

Giordano celebrates 30 years of operations in the Middle East          

Giordano celebrates 30 years of operations in the Middle East          

by admin
March 20, 2023

Global Video Management System (VMS) Market to Reach $21 Billion by 2027

Global Image Sensors Market to Reach $43.7 Billion by 2030

by admin
March 20, 2023

WorldVest Launches Africa Gold Corporation to Finance Gold Production

WorldVest Launches Africa Gold Corporation to Finance Gold Production

by admin
March 20, 2023

Informatic program to help drug discovery in Africa – Technology Today

by admin
March 20, 2023

BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

Correction: BioMap and MBZUAI team up on joint biocomputing lab to promote sustainable development and human health in the Middle East

by admin
March 20, 2023

Weekly Political Compass 3.20.23 | Teneo

Weekly Political Compass 3.20.23 | Teneo

by admin
March 20, 2023

MENANEWS provides press release distribution services for businesses, organizations and other entities with the need to reach media outlets in Europe, Middle east and Africa (MENANEWS) Submit press release or contact us today.

Share us

Subscribe To Our Newslatter

    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us
    Menu
    • Middle East
    • North Africa
    • Global
    • Business
    • Finance
    • Technology
    • Press
    • About Us
      • Press Release Distribution Services
      • Submit Press Release
      • Contact Us

    Browse by Category-

    Middle-East/ North Africa/ Global/ Business/ Finance / Technology/ Press/ About Us / PR Services / Submit PR / Contact us

    © 2023 Copyright MENANEWS

    Share us

    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Share on pinterest
    Pinterest